Clinical Trials Logo

EGFRI Induced Acneiform Lesions clinical trials

View clinical trials related to EGFRI Induced Acneiform Lesions.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04759664 Recruiting - Clinical trials for EGFRI Induced Acneiform Lesions

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

Start date: April 12, 2021
Phase: Phase 2
Study type: Interventional

The study evaluates the efficacy and safety of two strengths of LUT014 Gel topically applied once a day for 4 weeks, compared to placebo, in metastatic colorectal cancer (mCRC) patients who developed Grade 2 or non-infected Grade 3 EGFRI induced acneiform lesions